Vivotecnia Research is a contract research organization offering preclinical and toxicology studies for pharma and biotech clients.
Founded in 2000 by Andres König in Madrid, Spain, Vivotecnia Research is a contract research organization (CRO) providing preclinical safety, toxicology and pharmacokinetic studies under Good Laboratory Practice standards. Clients include pharmaceutical, biotech and chemical companies across Europe, North America and other markets. It raised funding from Clave Mayor and Möbius Corporate Venture Capital in June 2007 and reported USD 2.10 mn revenue and USD 534,526 EBITDA in its latest year. Its listed stage is Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in